Novartis Investigative Site

Herston QLD 4006

1 studies enrolling now · 6 studies all time

What they study most

Fallopian Tube Cancer, Follicular Lymphoma, Islet Cell Carcinoma, Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program, Myelogenous Leukemia, Neuroendocrine Carcinoma, Neuroendocrine Tumor, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Neoplasms, Peritoneal Neoplasms

Studies at this site

• CAR-T Long Term Follow Up (LTFU) Study — Recruiting now
• Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma — Completed
• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer — Completed
• Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy — Completed
• Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) — Stopped early